Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee P Shulman

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Menopause (New York, N.Y.)|September 10, 2002
Letter to the editorLee P Shulman
Menopause (New York, N.Y.)|October 29, 2011
The adverse impact of hormone therapy discontinuation on bone health: initiating a more balanced and comprehensive assessment of the impact and role of postmenopausal hormone therapyLee P Shulman
Current Pain and Headache Reports|July 29, 2010
Gynecological management of premenstrual symptomsLee P Shulman
American Journal of Obstetrics and Gynecology|March 8, 2011
One small step and one giant leap for noninvasive prenatal screening: an editorialLee P Shulman
Current Women'S Health Reports|January 11, 2003
Fetal cells in maternal bloodLee P Shulman
Treatments in Endocrinology|August 28, 2004
17 beta-estradiol/levonorgestrel transdermal system. A viewpoint by Lee P. ShulmanLee P Shulman
Contraception|March 15, 2006
New recommendations for the periodic well-woman visit: impact on counselingLee P Shulman
Clinical Obstetrics and Gynecology|May 9, 2008
Müllerian anomaliesLee P Shulman
Journal of Women'S Health (2002)|June 27, 2006
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesteroneLee P Shulman
Drug Safety|July 16, 2015
Walking the Fine Line between Science and CultureLee P Shulman
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Menopause (New York, N.Y.)|September 10, 2002
Letter to the editorLee P Shulman
Menopause (New York, N.Y.)|October 29, 2011
The adverse impact of hormone therapy discontinuation on bone health: initiating a more balanced and comprehensive assessment of the impact and role of postmenopausal hormone therapyLee P Shulman
Current Pain and Headache Reports|July 29, 2010
Gynecological management of premenstrual symptomsLee P Shulman
American Journal of Obstetrics and Gynecology|March 8, 2011
One small step and one giant leap for noninvasive prenatal screening: an editorialLee P Shulman
Current Women'S Health Reports|January 11, 2003
Fetal cells in maternal bloodLee P Shulman
Treatments in Endocrinology|August 28, 2004
17 beta-estradiol/levonorgestrel transdermal system. A viewpoint by Lee P. ShulmanLee P Shulman
Contraception|March 15, 2006
New recommendations for the periodic well-woman visit: impact on counselingLee P Shulman
Clinical Obstetrics and Gynecology|May 9, 2008
Müllerian anomaliesLee P Shulman
Journal of Women'S Health (2002)|June 27, 2006
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesteroneLee P Shulman
Drug Safety|July 16, 2015
Walking the Fine Line between Science and CultureLee P Shulman
Pageof 11